(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals (NYSE:REGN) has seen a 5.97% decrease in its short percent of float, now at 1.89%. This indicates a more bullish sentiment compared to its peers, whose average short interest is 5.95%.
October 03, 2024 | 5:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Regeneron Pharmaceuticals has experienced a 5.97% decrease in short interest, now at 1.89% of float, suggesting a more bullish sentiment compared to its peers with an average of 5.95%.
The decrease in short interest suggests that investors are becoming more bullish on Regeneron Pharmaceuticals. With a short interest of 1.89%, which is lower than the peer average of 5.95%, this could lead to a positive short-term impact on the stock price as it indicates reduced bearish sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100